CN Stock MarketDetailed Quotes

Jafron Biomedical (300529)

Watchlist
  • 20.12
  • -0.20-0.98%
Market Closed Jan 7 15:00 CST
16.07BMarket Cap33.37P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jafron Biomedical (300529) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Disposable use of hemoperfusion apparatus965.22M85.09%
Total special adjustments167.69M14.78%
Other business1.5M0.13%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Medical device manufacturing industry2.67B99.71%
Other7.81M0.29%

By Country/Region

Currency:CNY
2024/FY
Stock NameRevenueRatio
Territory2.62B97.78%
Overseas59.36M2.22%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.34%
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +9.84%
4
JD HEALTH
06618
+8.85%
5
ALI HEALTH
00241
+8.61%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.14%
Sample Name
Sample Code
 +5.27%
Sample Name
Sample Code
 +3.37%
4
Block
XYZ
+2.50%
5
Microsoft
MSFT
+2.06%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -